INCORPORATION OF RISK ASSESSMENT TOOL IMPACTS PATIENT AND GASTROENTEROLOGIST CONFIDENCE AND TREATMENT DECISION MAKING IN BIONAIVE CROHN’S DISEASE
| العنوان: | INCORPORATION OF RISK ASSESSMENT TOOL IMPACTS PATIENT AND GASTROENTEROLOGIST CONFIDENCE AND TREATMENT DECISION MAKING IN BIONAIVE CROHN’S DISEASE |
|---|---|
| المؤلفون: | Ryan Ungaro, Anish Patel, Shumin Rui, Darwin Jimenez, Drew Helmus, Ksenia Gorbenko, Marla Dubinsky, Laurie Keefer |
| المصدر: | Inflammatory Bowel Diseases. 29:S24-S25 |
| بيانات النشر: | Oxford University Press (OUP), 2023. |
| سنة النشر: | 2023 |
| مصطلحات موضوعية: | Hepatology, Gastroenterology, Immunology and Allergy |
| الوصف: | BACKGROUND Clinical guidelines recommend the incorporation of risk stratification assessments when making decisions about Crohn’s disease (CD) treatment. We aimed to evaluate if patient and gastroenterologist (GI) decision making and confidence about starting or changing therapy were impacted by reviewing a CD risk stratification assessment. METHODS We conducted a multicenter, prospective study evaluating the impact of a risk stratification tool on decision making by GIs and biologic naïve adult CD patients considering starting or changing therapy. Medical records were reviewed by a GI at the organizing site to determine risk according to the American Gastroenterological Association (AGA) Crohn’s Disease Care Pathway risk assessment tool. Patients with any risk factors for rapid disease progression (age RESULTS 47 patient-GI pairs were enrolled across 14 sites. Among CD patients, mean age was 40.2 years, 59% were men, 70% were white, 80% had inflammatory (B1) disease behavior, 74% had no prior CD-related hospitalizations, and 82% no prior CD-related surgeries. 64% of patients were deemed moderate-high risk and 36% low risk by AGA criteria. In comparison, 40% of patients self-assessed their risk as moderate-high at baseline. The most common moderate-high risk factors were age CONCLUSION Incorporation of a simple risk stratification assessment when considering treatment change in CD can assist in patient and GI decision making. Low risk assessments are associated with lower confidence in decision making. |
| تدمد: | 1536-4844 1078-0998 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5c7a3f3b2abe057ecf3d7b71e7c0ba6 https://doi.org/10.1093/ibd/izac247.047 |
| حقوق: | CLOSED |
| رقم الأكسشن: | edsair.doi.dedup.....c5c7a3f3b2abe057ecf3d7b71e7c0ba6 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15364844 10780998 |
|---|